贲门失弛缓症内镜治疗17例

来源 :世界华人消化杂志 | 被引量 : 0次 | 上传用户:zxg520
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的贲门失弛缓症为少见病,疑难病。既往有效的治疗方法甚少。为寻求有效的治疗方法,提高本病的治愈率,近年来我们开展了用Microvasive气囊扩治疗本病,受到显著疗效。方法用日本OLYPUS公司生产的电子胃镜,美国波士顿生产的Microvasive扩张气囊。首先将气囊经口送入食管内,在胃镜直视下将气囊置予贲门处,注气达到所需压力,使狭窄的贲门得以扩张。结果 17例贲门失弛缓症的患者近期疗效达100%,远期疗效正在观察之中。结论内镜直视下用Microvasive气囊扩张治疗贲门失弛缓症,疗效可靠,操做简便,应成为治疗该病的首选方法。 The purpose of achalasia is rare, difficult disease. Past effective treatment is rare. In order to seek effective treatment, improve the cure rate of this disease, in recent years we carried out with Microvasive balloon expansion of the disease, by a significant effect. Methods The electron gastroscope produced by Japan OLYPUS company, Microvasive expansion balloon produced in Boston, USA. First of all, the balloon is delivered orally into the esophagus, the balloon under the gastroscope to the cardia, gas injection to the desired pressure, so that the narrow cardia to be expanded. Results 17 cases of achalasia in patients with short-term effect of up to 100%, long-term efficacy is being observed. Conclusion Endoscopic treatment with Microvasive balloon dilatation for the treatment of achalasia has reliable curative effect and simple operation. It should be the first choice for the treatment of this disease.
其他文献